Unwavering commitment to research and development, ensuring the highest quality and efficacy of their products.
Wide range of innovative and life-saving pharmaceutical drugs and medical devices.
Strong focus on patient-centricity and improving access to healthcare globally.
Proven track record of successful treatments in various therapeutic areas.
Continuous investment in cutting-edge technologies and partnerships to drive scientific advancements.
Takeda's products are primarily available for purchase on the Ubuy ecommerce store.
Entyvio is a prescription medication used for treating ulcerative colitis and Crohn's disease. It works by targeting specific molecules involved in inflammation.
Ninlaro is a chemotherapy medication used in the treatment of multiple myeloma, a type of blood cancer. It inhibits enzymes necessary for cancer cell survival and growth.
Adcetris is an antibody-drug conjugate used to treat Hodgkin lymphoma and certain types of systemic anaplastic large cell lymphoma. It binds to cancer cells and delivers a toxin to kill them.
Takeda specializes in a wide range of therapeutic areas, including gastroenterology, oncology, rare diseases, neurology, and immunology.
Yes, Takeda's products are available in many countries globally, ensuring broad access to their life-saving treatments.
Yes, Takeda has various patient assistance programs in place to support eligible patients in accessing their medications.
Yes, Takeda actively collaborates with academic institutions, other pharmaceutical companies, and research organizations to drive scientific advancements and bring innovative treatments to patients.
Yes, Takeda is committed to sustainable business practices and aims to reduce its environmental impact through initiatives like energy conservation, waste reduction, and responsible manufacturing.